Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the 2020 Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator. The antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and most effective HIV treatment regimen currently available… Read More »